GPAT
GP-Act III Acquisition Corp.
There isn't enough reported data to score GPAT yet.
GPAT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
GPAT's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like GPAT.
GPAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 30x | $7.17 | -35% |
| Fair | 31x | $7.48 | -32% |
| Expensive | 40x | $9.56 | -14% |
| Current | 46x | $11.07 | — |
Historical ranges are pointers, not guarantees.
GPAT's PE is 46x, but its earnings don't support one, so it isn't a reliable read right now.
GPAT Forward outlook
There aren't enough analyst estimates for GPAT to show an outlook.
GPAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.24 | -33% |
| Q1 2026 | $0.31 | -11% |
| Q4 2025 | $0.33 | +27% |
GPAT's earnings per share have fallen from their peak: $0.24 over the past year, against $0.36 in mid-2025.
GPAT Quarterly Revenue
GPAT's revenue is shrinking: $0 last quarter.
GPAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$188.8K | -$58.6K |
| Q1 2026 | -$108.2K | +$43.7K |
| Q4 2025 | $10.8K | +$40.8K |
| Q3 2025 | -$100.9K | -$42.6K |
| Q2 2025 | -$130.3K | +$318.3K |
| Q1 2025 | -$151.9K | -$103.9K |
| Q4 2024 | -$29.9K | -$19.4K |
| Q3 2024 | -$58.3K | -$58.1K |
GPAT's free cash flow was −$387,103 over the past year, against −$370,389 the year before. Free cash flow isn't a meaningful measure for financial services companies like GPAT.
GPAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -21% | -5.9M shares |
| 1 year | -36% | -13.1M shares |
| 3 years | -27% | -8.4M shares |
GPAT has 23M diluted shares, down 36% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
GPAT hasn't bought back shares in the past year.
GPAT Net Leverage
GPAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.1 | Neutral |
| Stochastic | 69.8 | Neutral |
GPAT's weekly RSI is 56 (neutral) and its Stochastic is 70 (neutral).
GPAT PE vs Financial Services Sector
| Metric | GPAT | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 13x | 251% above |
| PE % | 94 | 24 | 70 pts above |
GPAT is trading at 46x earnings, a 251% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
GPAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.1 | 0.1% above |
| 20 week MA | $11.0 | 0.4% above |
| 50 week MA | $10.9 | 1.7% above |
| 100 week MA | $10.7 | 3.7% above |
GPAT is in an uptrend: it's above all four of its weekly moving averages, and 3.7% above its 100-week average.
GPAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $9.99 | $10.2 | +1.6% |
| 2025 | $10.2 | $10.7 | +5.2% |
| 2026 YTD | $10.7 | $11.1 | +3.7% |
GPAT has finished every year since 2024 higher, and it's up 3.7% so far in 2026.